RAPPORT THERAPEUTICS INC (RAPP) Stock Cash Flow
USA - NASDAQ:RAPP - US75383L1026 - Common Stock
25.17 USD
-0.33 (-1.29%)
25.17 USD
0 (0%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
| Net Income | -97.70M | -78.31M | -34.79M | -10.65M | |||
| Depreciation Amortization | 1.01M | 839.00K | 112.00K | 15.00K | |||
| Income Taxes - Deferred | undefined | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | 1.24M | -2.42M | 2.65M | 1.49M | |||
| Interest Paid | undefined | null | null | null | |||
| Taxes Paid | undefined | null | null | null | |||
| Other non cash items | 18.23M | 15.06M | 4.84M | 5.91M | |||
| OPERATING CASH FLOW | -77.22M | -64.83M | -27.18M | -3.24M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
| Capital Expenditure | -673.00K | -2.40M | -1.64M | -284.00K | |||
| Other Investing Activity | 19.45M | -167.74M | -77.22M | -5.00M | |||
| INVESTING CASH FLOW | 18.78M | -170.14M | -78.86M | -5.28M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
| Debt Issued/Reduced | undefined | null | null | 8.00M | |||
| Stock Issued/Repurchased | 648.00K | 221.63M | 85.35M | 31.00K | |||
| Dividend Paid | undefined | null | null | null | |||
| Other Financing Activity | undefined | 0 | 59.79M | 31.65M | |||
| FINANCING CASH FLOW | 270.48M | 221.63M | 145.14M | 39.69M | |||
| Exchange Rate Effect | undefined | null | null | null | |||
| CHANGE IN CASH | 212.04M | -13.34M | 39.09M | 31.16M | |||
| FREE CASH FLOW | |||||||
| Operating Cash Flow | -77.22M | -64.83M | -27.18M | -3.24M | |||
| Capital Expenditure | -673.00K | -2.40M | -1.64M | -284.00K | |||
| FREE CASH FLOW | -77.89M | -67.23M | -28.82M | -3.53M | |||
All data in USD